Three studies encompassing dozens of ancient genomes are offering a closer look at complex historical population spread in North, Central, and South America.
According to the researchers, led by a team at the University of Cambridge, detecting somatic brain mutations in patients during their life may increase diagnostic precision and lead to new therapies.
A search for genetic contributors to flood-tolerant rice led to a distinct version of the gibberellin biosynthesis gene SD1.
Researchers genotyped Y chromosome markers in almost 100 ancient horse DNA samples spanning 5,000 years.
Teams studying kidney and skin cancers independently implicated SWI/SNF chromatin remodeling mutations in checkpoint blockade immunotherapy response.
Eight draft microbial genomes were generated using DNA in Neanderthal plaque, as part of study aimed at uncovering Neanderthal diet, behavior, and more.
Response to a low toxicity drug called decitabine was most pronounced in acute myeloid leukemia and myelodysplastic syndrome cases with TP53 mutations.
A year after launching the test in the US, the company is making it available in more than 100 countries, partnering with distributors in Israel, Turkey, and Finland.
The Belgian company is also developing new tests and applications with its Multiplex Amplification of Specific Targets for Resequencing technology.
Two separate studies concluded that in most SEO cancer cases what they are seeing are two separate early-stage tumors, instead of late-stage cancer.
Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.
Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.
A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.
In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.